(株)ヘリオスの貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証GRT | 医薬品 | 4593/ - | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2017/02/24 | 日証協 | 977,602株 | +6.7% | 122,602株 | +178.62% | 560,007株 | -1.44% | 63,520株 | +182.19% |
2017/02/17 | 日証協 | 916,202株 | +3.2% | 44,004株 | -75.82% | 568,202株 | +2.21% | 22,510株 | -79.6% |
2017/02/10 | 日証協 | 887,800株 | +10.91% | 181,999株 | -35.05% | 555,892株 | +7.32% | 110,354株 | +22.99% |
2017/02/03 | 日証協 | 800,451株 | +27.45% | 280,202株 | +766.16% | 517,995株 | +23.51% | 89,726株 | +176.93% |
2017/01/27 | 日証協 | 628,051株 | -8.53% | 32,350株 | -22.42% | 419,379株 | -11.52% | 32,400株 | +183.96% |
2017/01/20 | 日証協 | 686,601株 | -1.32% | 41,700株 | -27.1% | 473,979株 | +1.11% | 11,410株 | -74.13% |
2017/01/13 | 日証協 | 695,801株 | -6.73% | 57,200株 | +793.75% | 468,769株 | -5.75% | 44,100株 | +384.62% |
2017/01/06 | 日証協 | 746,001株 | -4.83% | 6,400株 | -49.18% | 497,369株 | -2.98% | 9,100株 | -51.96% |
2016/12/30 | 日証協 | 783,901株 | -5.3% | 12,594株 | -32.29% | 512,638株 | -9.37% | 18,941株 | +19.89% |
2016/12/22 | 日証協 | 827,800株 | +0.24% | 18,601株 | -90.81% | 565,663株 | +0.27% | 15,799株 | -84.6% |
2016/12/16 | 日証協 | 825,801株 | +13.68% | 202,402株 | +586.11% | 564,159株 | +10.97% | 102,615株 | +134.82% |
2016/12/09 | 日証協 | 726,401株 | +2.43% | 29,500株 | +109.21% | 508,371株 | +2.36% | 43,700株 | +103.21% |
2016/12/02 | 日証協 | 709,201株 | +0.25% | 14,101株 | -82.97% | 496,666株 | -0.04% | 21,505株 | +46.26% |
2016/11/25 | 日証協 | 707,400株 | -0.62% | 82,800株 | +128.1% | 496,862株 | +0.42% | 14,703株 | +2.11% |
2016/11/18 | 日証協 | 711,800株 | -4.48% | 36,300株 | -19.87% | 494,762株 | -4.59% | 14,399株 | -62.33% |
2016/11/11 | 日証協 | 745,201株 | +3.74% | 45,302株 | -8.12% | 518,546株 | +3.58% | 38,227株 | +72.19% |
2016/11/04 | 日証協 | 718,301株 | +3.04% | 49,307株 | +18.52% | 500,643株 | +2.37% | 22,200株 | -41.12% |
2016/10/28 | 日証協 | 697,101株 | -2.86% | 41,601株 | +2.97% | 489,044株 | -4.38% | 37,701株 | +10.84% |
2016/10/21 | 日証協 | 717,601株 | +7.46% | 40,400株 | -34.74% | 511,447株 | +3.61% | 34,014株 | -11.44% |
※株式分割は考慮していませんのでご注意ください。
Page Top